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Abstract
Surgical treatment of metastatic spinal cord compression is controversial. The purpose of this
study was to investigate the effectiveness of our current surgical treatments and the use of spinal
instrumentation. In this retrospective study covering the years between 1990 and 2006, 100 pa-
tients with spinal metastases which were secondary to various cancers underwent posterior and/or
anterior decompression with spinal stabilization for the purposes of reduction of pain, and/or to
help correct or improve neurological deficits. The group was made up of 60 men and 40 women
whose ages ranged from 16 to 83 years (average of 60 years), and the average follow-up period
was 14 months. The effect of treatment upon pain relief and neural deficits was assessed, and
the cumulative survival rate was calculated by the Kaplan-Meier method. The average surgical
time was 185min. This was calculated based on the following times, listed here with the surgery
type:178min for posterior surgery;245min for anterior surgery;465 min for combined surgery;and
475min for total en bloc spondylectomy. Average blood loss during surgery was 1,630 ml for
posterior surgery, 1,760 ml for anterior surgery, 1,930 ml for combined surgery, and 3,640 ml for
total en bloc spondylectomy. Preoperative pain and paralysis were improved by 88% and 53%,
respectively. In regards to surgical complications, postoperative epidural hematoma was observed
in 2 patients, and instrumentation-related infection was observed in 1. Only 2 patients died within
2 months of surgery. In conclusion, posterior and/or anterior decompression with spinal stabiliza-
tion is a safe and effective treatment for patients with spinal metastases, and can improve their
quality of life.
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Surgical treatment of metastatic spinal cord compression is controversial.  The purpose of this study 
was to investigate the eﬀectiveness of our current surgical treatments and the use of spinal instrumen-
tation.  In this retrospective study covering the years between 1990 and 2006,  100 patients with spinal 
metastases which were secondary to various cancers underwent posterior and/or anterior decompres-
sion with spinal stabilization for the purposes of reduction of pain,  and/or to help correct or improve 
neurological deﬁcits.  The group was made up of 60 men and 40 women whose ages ranged from 16 to 
83 years (average of 60 years),  and the average follow-up period was 14 months.  The eﬀect of treat-
ment upon pain relief and neural deﬁcits was assessed,  and the cumulative survival rate was calcu-
lated by the Kaplan-Meier method.  The average surgical time was 185min.  This was calculated based 
on the following times,  listed here with the surgery type: 178min for posterior surgery; 245min for 
anterior surgery; 465min for combined surgery; and 475min for total en bloc spondylectomy.  
Average blood loss during surgery was 1,630ml for posterior surgery,  1,760ml for anterior surgery,  
1,930ml for combined surgery,  and 3,640ml for total en bloc spondylectomy.  Preoperative pain and 
paralysis were improved by 88ｵ and 53ｵ,  respectively.  In regards to surgical complications,  postop-
erative epidural hematoma was observed in 2 patients,  and instrumentation-related infection was 
observed in 1.  Only 2 patients died within 2 months of surgery.  In conclusion,  posterior and/or ante-
rior decompression with spinal stabilization is a safe and eﬀective treatment for patients with spinal 
metastases,  and can improve their quality of life.
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ones,  especially the spinal column,  are target 
organs for distant metastasis of malignant 
tumors.  Prostate,  breast,  lung,  and thyroid cancers 
frequently metastasize to bones [1],  with 80 percent 
of bone metastases occurring in the lumbar spine,  and 
the remainder concentrated mostly in the ribs,  ster-
num,  and pelvis [2].  Primary malignant spinal tumors 
and solitary vertebral metastases of selected tumors 
in the spine are indications for spinal surgery.  Recent 
advances in spinal instrumentation,  coupled with new 
developments in surgical technology,  have made vari-
ous new surgical modalities available for treating 
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spinal metastases [3].
　 It is important during the treatment of metastatic 
spinal tumors for individual physicians to select the 
appropriate therapy.  The purpose of this study was to 
investigate the eﬀectiveness of our current surgical 
treatments and the use of spinal instrumentation.
Patients and Methods
　 In this retrospective study,  100 patients with spi-
nal metastases which were secondary to various can-
cers underwent surgery between 1990 and 2006 for 
the purposes of spinal fusion,  the reduction of pain,  
and/or the correction or improvement of neurological 
deﬁcits.  (Patients who were not followed for more 
than 6 months were excluded from the ﬁnal data in 
this study. ) The group consisted of 60 men and 40 
women who ranged in age from 16 to 83 years (aver-
age age of 60 years) at the time of surgery.  Our surgi-
cal indications for spinal metastasis were: 1) pain 
and/or paralysis due to spinal instability,  which was 
deﬁned as more than 5mm translation and/or 10 
degrees angulation; 2) rapidly progressing paraly-
sis; 3) concomitant deﬁnitive diagnosis of a spinal 
lesion of unknown origin or a well-controlled primary 
lesion; and,  most importantly,  4) a localized meta-
static lesion.  When metastasis involved only 1 or 2 
vertebrae,  an anterior or anterior/posterior proce-
dure was used for total tumor resection.  Multiple 
lesions principally were treated via a posterior proce-
dure for neural decompression.  Postoperative follow-
up periods ranged from 1 month to 7 years,  with a 
mean of 14 months.
　 Primary lesions are summarized in Table 1.  There 
were 17,  57,  and 26 patients with metastatic lesions 
at the cervical,  thoracic,  and lumbar levels,  respec-
tively.  As to surgical procedures,  78 patients were 
treated via a posterior approach,  10 via an anterior 
approach,  and both anterior and posterior approaches 
were used in 4 patients.  (Of the patients treated via a 
posterior surgical approach only,  73 received a 
laminectomy plus posterior stabilization,  and 5 
received a laminectomy alone. ) The remaining 8 
patients underwent total en bloc spondylectomy via a 
posterior approach.  It is worth noting,  however,  that 
such a treatment is only indicated for patients whose 
primary tumors had a low degree of malignancy,  such 
as renal and thyroid cancers,  and whose bony meta-
static lesions are limited to one vertebral body (Table 
2).
　 Before surgery,  patients were examined with plain 
anterior-posterior and lateral radiographs of the 
aﬀected spinal segment,  computed tomography with 
sagittal reconstructions of the involved vertebra,  and 
magnetic resonance imaging.  Computed tomography of 
the chest,  abdomen,  and brain were performed in each 
patient with suggestive clinical ﬁndings.  Patients with 
radiosensitive tumors and mild paralysis received 
preoperative irradiation,  whereas,  generally,  those 
requiring emergency surgery due to severe paralysis 
were irradiated postoperatively with 30ﾝ50Gy.  Some 
patients did not receive radiation treatment because 
their tumors were considered to be insensitive to 
radiation therapy.
　 Clinical data relating to pain and paralysis were 
analyzed prior to surgery and compared with observa-
tions performed 1ﾝ2 months after surgery.  In each 
time period,  pain was graded from 1 to 4 (Table 3) 
and paralysis was assessed by Frankelʼs classiﬁcation 
system [4] (Table 4).  The eﬃcacy rate (the percent-
age of patients showing improvement or maintaining 
the best grade within a certain category) was calcu-
lated for each variable (eﬃcacy rate＝best score or 
improvement / total×100ｵ).
　 Spinal instrumentation systems were selected for 
all patients with metastatic spinal tumors.  The verte-
brae superiorly and inferiorly adjacent to the aﬀected 
vertebra became involved for stabilization.
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Table 1　 Primary lesions of metastatic vertebral tumors
Lung cancer 19 Thyroid cancer 6
Myeloma 13 Stomach cancer 3
Prostate cancer 11 Liver cancer 3
Breast cancer 10 Unknown origin 4
Renal cancer  7 Others 24
Table 2　 Surgical procedure
Anterior Posterior Anterior & Posterior TES
＊ Total
Cervical 10  6 1 0 17
Thoracic  0 50 1 6 57
Lumbar  0 22 2 2 26
Total 10 78 4 8 100
TES＊＝Total en-bloc Spondylectomy
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Results
　 The duration of surgery for all procedures ranged 
from 95 to 975 min (average of 185min),  with means 
of 178min for posterior procedures,  245min for 
anterior procedures,  465min for anterior plus poste-
rior procedures,  and 475min for total en bloc spon-
dylectomies.  Blood loss for all surgeries ranged from 
110 to 18,000ml (average of 1,100ml),  and the mean 
blood loss for each procedure was 1,630ml for poste-
rior procedures,  1,760ml for anterior procedures,  
1,930ml for anterior plus posterior procedures,  and 
3,640ml for total en bloc spondylectomies.
　 Preoperative and postoperative pain level scores 
are summarized in Table 5.  The eﬃcacy rate was 
88ｵ,  and no patients had an increase in pain level.  
Five of 10 patients who showed no pain reduction 
after the initial surgery also underwent laminectomy 
plus stabilization via a posterior approach for lesions 
that had metastasized from the lungs.
　 According to the Frankelʼs paralysis classiﬁcation 
system,  postoperative paralysis grades were A,  B,  C,  
D,  and E in 5,  9,  10,  54,  and 22 patients,  respec-
tively,  with a mean eﬃcacy rate of 53ｵ (Table 6).  
Paralysis worsened in 7 patients (7ｵ); it is perhaps 
of note that these patientsʼ mean blood loss of 4,618ml 
was signiﬁcantly higher than the blood loss of the 
other patients (1,672ml,  p＜0.01).
　 The postoperative cumulative survival rate of all 
patients was 57ｵ after 1 year,  35ｵ after 2 years,  
and 22ｵ after 3 years (Fig.  1).  Correlated to pri-
mary lesions,  the one-year survival rates were 100ｵ 
for renal cancer and multiple myeloma; 88ｵ for 
prostate cancer; 75ｵ for thyroid cancer; 63ｵ for 
breast cancer; 32ｵ for lung cancer; and 0ｵ for 
liver cancer (Fig.  2).  Patients with lung or liver 
cancer had signiﬁcantly poorer outcomes than patients 
with other forms of cancer (p＜0.01),  and the majority 
of them died within one year of surgery.  Only 2 
patients died within 2 months of surgery.
　 Postoperative epidural hematoma was observed in 
2 patients and instrumentation-related infection was 
observed in one.  However,  these were the only appar-
ent surgical complications,  and neither neurovascular 
injuries nor instrumentation breakdowns were 
recorded.
　 Case presentation. The patient was a 
68-year-old woman with a metastatic second lumbar 
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Table 3　 Pain grade
Ⅰ no pain
Ⅱ mild pain,  no need NSAIDs
Ⅲ moderate pain,  need for NSAIDs
Ⅳ severe pain,  need for morphine
Table 4　 Frankelʼs grade
A complete motor and sensory loss
B complete motor and incomplete sensory loss
C some motor function but no practical use
D useful motor function,  incomplete sensory loss
E normal motor and sensory function
Table 5　 Preoperative and post operative pain grade
Pain grade Preoperative Postoperative
Ⅰ no  5 51
Ⅱ mild 15 36
Ⅲ moderate 62 11
Ⅳ severe 18 2
Table 6　 Preoperative and post operative Frankelʼs grade
Frankelʼs grade Preoperative Postoperative
A  8 5
B  9 9
C 41 10
D 36 54
E  6 22
0 1 2 3 4 5
0
20
40
60
80
100
(%)
(year)
Fig. 1　 Total survival rate.  The postoperative,  cumulative sur-
vival rate in all patients was 57% after 1 year,  35% after 2 years,  
and 22% after 3 years.
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tumor arising from thyroid cancer.  She presented 
with back pain and paralysis; preoperative MRI and 
CT imaging showed a collapse of the second lumbar 
spine and dural tube compression.  A CT-guided 
biopsy conﬁrmed a metastatic lesion resulting from 
thyroid cancer,  while systemic examination revealed 
no clear evidence of metastases in other regions.  
Total en bloc spondylectomy of the second lumbar 
spine was performed according to Tomitaʼs technique 
[5],  and the region from T12 to L4 was rigidly ﬁxed 
posteriorly using the TSRH system (Medtronic 
Sofamor Danek inc,  Memphis,  TN,  USA) (Fig.  3).  
The patient was completely relieved from back pain 
and paralysis,  and could once again stand up and walk.  
Three and a half years after surgery,  she maintains 
independent ambulation.
Discussion
　 Surgical indications and procedures for 
metastatic spinal tumors. Metastatic spinal 
tumors invariably create substantial restrictions on 
daily activities due to pain and/or paralysis resulting 
from the destruction of the spinal cord and its support 
system [6].  Recent developments in spinal instru-
mentation and advances in spine-related surgical 
techniques now allow for vastly improved,  more com-
prehensive,  aggressive local treatment that can more 
fully facilitate healing in the aﬀected area; in some 
cases,  the use of spinal column support is a critical 
component in such treatment [3].  Our indications for 
surgery were: 1) pain and/or paralysis due to spinal 
instability (more than 5mm translation and/or 10 
degrees angulation); 2) rapidly progressing paraly-
sis; 3) concomitant deﬁnitive diagnosis of a spinal 
lesion of unknown origin or a well-controlled primary 
lesion; and 4) a localized metastatic lesion.  This last 
indication was of critical importance,  as it generally 
made aggressive local treatment both possible and 
necessary.
　 There are some useful scoring systems for evaluat-
ing surgical indications for metastatic spinal tumors 
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Fig. 2　 The survival rate according to primary cancer.  For pri-
mary lesions,  the 1-year survival rates were 100% for renal cancer 
and multiple myeloma,  88% for prostate cancer,  75% for thyroid 
cancer,  63% for breast cancer,  and 32% for lung cancer.
Fig. 3　 68-year-old woman with thyroid cancer.  Preoperative CT and MRI show metastatic L2 tumor,  arising from thyroid cancer.  
Second lumbar spine collapse and dural tube compression were imaged.  En bloc spondylectomy of L2 was performed according to 
Tomitaʼs technique.
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[7,  8].  Tokuhashiʼs scoring system includes 6 param-
eters: 1) the patientʼs general condition : 2) the num-
ber of extraspinal bone metastases; 3) the number of 
metastases in the vertebral body; 4) metastases to the 
major internal organs; 5) the primary site of the 
cancer; and 6) the severity of spinal cord palsy.  The 
systemʼs range of scores is from 0 to 15,  with exci-
sional surgery recommended for those cases who score 
above 9 points,  and a palliative operation indicated 
for those who score under 5 points [7].
　 It has been reported that the life expectancy of 
patients with metastatic vertebral tumors--such as lung,  
stomach,  esophagus,  pancreas,  or liver cancerﾝis 
shorter than that of patients suﬀering from other 
primary cancers [7,  8].  In this study,  the same ten-
dency was observed in patients with lung,  stomach,  
and liver cancer.  Surgeons who perform spinal surgi-
cal intervention upon patients diagnosed with these 
primary cancers may need to consider the implications 
of such data.
　 Eﬀectiveness of and problems with spinal 
instrumentation. Spinal instrumentation is 
required to achieve spinal support immediately after 
surgery.  The insertion of a pedicle screw at the tho-
racolumbar level is not a problem,  but may cause 
complications,  such as neurovascular injury,  if 
applied at the cervical level.  Thus one should use 
pedicle screws at the cervical level only after carefully 
considering the potential risks involved.  Moreover,  
special care should be taken with regard to the poten-
tial for infection when using a cage,  which is required 
in many cases for the reconstruction of anterior sup-
port following the extraction of a vertebral body.
　 Surgical results and problems. Recent 
reports show that 67 to 91ｵ of patients who receive 
irradiation and 68 to 100ｵ of those who undergo 
surgical treatment for spinal metastases experience 
pain relief [9].  Due to their high radiosensitivities,  
the tumors of malignant lymphoma,  multiple myeloma,  
breast cancer,  and prostate cancer should always be 
treated with preoperative radiotherapy [10].  Unfor-
tunately,  the results are not as encouraging―or as 
even―when one considers the eﬀects of irradiation on 
paralysis.  For one thing,  irradiation is not very eﬀec-
tive for improving paralysis when compared to surgical 
treatment [10].  For another,  the overall reported 
eﬃcacy rate for the improvement of paralysis by 
irradiation varies greatly,  ranging from 32 to 89ｵ.  
The eﬃcacy of surgery is aﬀected by factors such as 
the presence of primary lesions,  the degree of preop-
erative paralysis,  and the type of surgical procedure 
performed [7].  Paralysis in patients with lung or 
stomach cancer tended to respond poorly to treatment,  
which suggests that the histological type of the pri-
mary lesion by itself aﬀects not only the patientʼs vital 
prognosis,  but also the improvement of paralysis.
　 Ibrahim et al.  reported on the surgical treatment 
of 223 spinal extradural metastases [11].  The inci-
dence of perioperative death (within 30 days) was 
5.8ｵ in this study and 2ｵ in our study.  Postopera-
tively,  71ｵ of the patients noted a reduction in pain 
level,  and 73ｵ of the patients were able to regain 
movement and/or improve their Frankel grade.  Our 
results were similar to this report,  so it appears that 
surgical intervention should be considered a safe and 
eﬀective treatment for patients with spinal metasta-
ses,  and one that can improve their quality of life.
　Since patients in our study whose paralysis wors-
ened after surgery tended to undergo signiﬁcantly 
greater blood loss during surgery,  it seems that the 
formation of a postoperative epidural hematoma may 
aggravate the paralysis.  Preoperative embolization 
should be performed as much as possible,  and is 
essential for the treatment of tumors which bleed more 
easily,  such as renal and thyroid cancers [12,  13].
　 Conclusions. Posterior and/or anterior 
decompression with spinal stabilization is a safe and 
eﬀective treatment for patients with spinal metasta-
ses,  and one that can improve their quality of life.  
Preoperative pain and paralysis were improved by 
88ｵ and 53ｵ,  respectively,  in this study.  However,  
patients with lung or liver cancer had signiﬁcantly 
poorer outcomes when compared with patients with 
other cancers.
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